Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07727239
NA

Temporal Interference Stimulation of Hypothalamus in Patients With Narcolepsy Type 1

Sponsor: Xijing Hospital

View on ClinicalTrials.gov

Summary

Narcolepsy type 1 (NT1) is a chronic brain disorder caused by selective loss or dysfunction of orexin (hypocretin) neurons in the lateral hypothalamus, for which current pharmacological treatments offer limited efficacy. Temporal interference (TI) stimulation is a recently developed noninvasive neuromodulation technique that enables focal modulation of deep brain structures. In this randomized, double-blind study, we developed a theta-burst patterned TI protocol and evaluated its effects in patients with NT1.

Official title: Efficacy and Safety of Temporal Interference Stimulation of Hypothalamus in Patients With Narcolepsy Type 1: A Randomised, Double-blind, Sham-Controlled, Single-Centre Trial

Key Details

Gender

All

Age Range

12 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2026-08-01

Completion Date

2027-12

Last Updated

2026-08-05

Healthy Volunteers

No

Interventions

DEVICE

Active Temporal Interference Stimulation

For the active TI stimulation, the current was applied for 40 minutes per session.

DEVICE

Sham Temporal Interference Stimulation

For the sham stimulation, a brief 30-second current was delivered at the beginning and at the end of each session, with no current applied in between.

Locations (1)

Xijing Hospital

Xi'an, Shaanxi, China